GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Hansen Pharmaceutical Co Ltd (SZSE:002412) » Definitions » Financial Strength

Hunan Hansen Pharmaceutical Co (SZSE:002412) Financial Strength : 9 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hunan Hansen Pharmaceutical Co Financial Strength?

Hunan Hansen Pharmaceutical Co has the Financial Strength Rank of 9. It shows strong financial strength and is unlikely to fall into distressed situations.

Good Sign:

Hunan Hansen Pharmaceutical Co Ltd shows strong financial strength.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Hunan Hansen Pharmaceutical Co's Interest Coverage for the quarter that ended in Sep. 2024 was 76.65. Hunan Hansen Pharmaceutical Co's debt to revenue ratio for the quarter that ended in Sep. 2024 was 0.09. As of today, Hunan Hansen Pharmaceutical Co's Altman Z-Score is 6.87.


Competitive Comparison of Hunan Hansen Pharmaceutical Co's Financial Strength

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Hansen Pharmaceutical Co's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Hansen Pharmaceutical Co's Financial Strength Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Hansen Pharmaceutical Co's Financial Strength distribution charts can be found below:

* The bar in red indicates where Hunan Hansen Pharmaceutical Co's Financial Strength falls into.



Hunan Hansen Pharmaceutical Co Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Hunan Hansen Pharmaceutical Co's Interest Expense for the months ended in Sep. 2024 was ¥-0.5 Mil. Its Operating Income for the months ended in Sep. 2024 was ¥40.6 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥0.0 Mil.

Hunan Hansen Pharmaceutical Co's Interest Coverage for the quarter that ended in Sep. 2024 is

Interest Coverage=-1*Operating Income (Q: Sep. 2024 )/Interest Expense (Q: Sep. 2024 )
=-1*40.625/-0.53
=76.65

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Hunan Hansen Pharmaceutical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

2. Debt to revenue ratio. The lower, the better.

Hunan Hansen Pharmaceutical Co's Debt to Revenue Ratio for the quarter that ended in Sep. 2024 is

Debt to Revenue Ratio=Total Debt (Q: Sep. 2024 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(79.795 + 0) / 854.144
=0.09

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Hunan Hansen Pharmaceutical Co has a Z-score of 6.87, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 6.87 is strong.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Hansen Pharmaceutical Co  (SZSE:002412) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Hunan Hansen Pharmaceutical Co has the Financial Strength Rank of 9. It shows strong financial strength and is unlikely to fall into distressed situations.


Hunan Hansen Pharmaceutical Co Financial Strength Related Terms

Thank you for viewing the detailed overview of Hunan Hansen Pharmaceutical Co's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Hansen Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Silver City Road, Long Ridge Industrial Park, Heshan District, Yiyang City, CHN, 413000
Hunan Hansen Pharmaceutical Co Ltd is producing Chinese and Western medicines. Its main dosage forms include large-volume injections, small-volume injections, oral liquids, tablets, hard capsules, granules, syrups, ointments, tinctures, and pills. The company's main products are Si Mo Tang Oral Liquid, Shuanquan Capsule, Ginkgo Biloba Capsule and Tianma Xingnao Capsule.
Executives
Luo Yong Qing Directors, executives
Liu Zheng Qing Directors, executives
Liu Ling An Director
Fu Jian Jun Executives
Liu Na Xin Independent director
Liu Hou Yao Directors, Directors, and Executives
He San Xing Directors, executives

Hunan Hansen Pharmaceutical Co Headlines

No Headlines